Taysha Gene Therapies to present TSHA-102 preclinical data at ASGCT meeting

April 27, 2026 5:21 PM

Taysha Gene Therapies Inc. (NASDAQ: TSHA) announced it will present new preclinical data supporting the design of TSHA-102 for Rett ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found